Angioedema and Urticaria: Issues and Management
Price: FREE for members and non-members
Session recorded on April 22, 2021
Speaker: John Hagan, MD
Viewers can earn credit by completing the posttest questions
This program is a collaboration between the American College of Allergy, Asthma and Immunology and the Allergy and Asthma Network.
There is no commercial support for this activity.
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Primary Care Providers
Upon completion of this activity learners should be able to:
1. recognize the heterogeneity of various subtypes of urticaria and angioedema and recognize other conditions which may mimic these conditions.
2. recognize patient care, medical knowledge and system-based practice.
3. recognize therapeutic modalities for management of chronic urticaria and angioedema.
All identified conflicts of interest have been resolved.
Michael Blaiss, MD, Planner
Disclosures: Consultant/Consulting fee: ALK, DBV, Hycor, Merck, Pfizer, Sanofi, Stallergenes Greer, PMD Healthcare
John Hagan, MD, Speaker
Disclosures: Primary Investigator/Contracted Research: Shire (Dyax)
- 1.00 AMA PRA Category 1 Credit™
- 0.00 Attendance